LOS ANGELES, March 8, 2005 (PRIMEZONE) -- Universal Detection Technology (OTCBB:UDTT) announced that its CEO, Mr. Jacques Tizabi, was interviewed by MoneyTV, a nationally syndicated television program.
Mr. Tizabi, among other topics, spoke about the current status of the threat of bio-terrorism and the global community's concerns over the possibility of a devastating terrorist attack involving germ warfare. Among his remarks, Mr. Tizabi mentioned the recent meeting hosted by the global police agency, Interpol, and how officials shied from detailing specific threats but warned that al Qaeda has stated its intention to use biological weapons. He also articulated about the recent move by the G7 countries to establish a germ warfare crisis center.
"In the years after the events of September 11, 2001, and the subsequent anthrax attacks, the world opened its eyes to a new threat, that of bio-terrorism. In a study by Professor Lawrence M. Wein, published by the Stanford Graduate School of Business, it was shown that the release of 2 pounds of weapons-grade anthrax from the height of 300 feet just upwind of a large U.S. city of 11.5 million people will result in 1.5 million infected individuals," said Mr. Tizabi. "We believe that one of the most important ingredients of any effective counter-bioterrorism response plan is the ability to monitor vulnerable areas constantly for airborne germs. Unless detected in early stages, a bio-terror attack can cause irreversible damages to the infrastructure of its target."
The interview will be aired nationwide on Dish Network On-Demand programming. Other airings include:
---------------- ----------------------- -------------------------
Location Availability Air Times
---------------- ----------------------- -------------------------
USA Cable TV, Broadcast TV, Saturdays, 9:30 AM, EST
DISH Network, DIRECTV Sundays, 11:00 AM EST,
8:00 AM PT
Wednesdays, 7:00 PM EST
---------------- ----------------------- -------------------------
Southern Cable TV, Broadcast TV, Saturdays, 6:30 AM, PT
California DISH Network, DIRECTV
---------------- ----------------------- -------------------------
Virgin Islands/ NBC-TV, WVGN Saturdays, 6:00 AM
Puerto Rico
---------------- ----------------------- -------------------------
Western Europe Bright Entertainment Wednesdays, 7:30 PM,
Network (BEN) Sky Digital No. 184
---------------- ----------------------- -------------------------
There will also be 837 other airings on various channels around the nation on Sunday, November 14th, 11:00 AM EST.
About MoneyTV
MoneyTV is a weekly television program debuted in 1996 and is broadcast nationally on Saturdays at 6:30 AM ET, Sundays at 6:30 AM PT, 8:00 AM ET, 11:00 AM ET and 11:30 AM PT, Mondays and Tuesdays at 11:30 AM PT and Wednesdays at 7:00 PM ET. MoneyTV is broadcast to 40 million TV homes in Western Europe, Wednesdays at 6:00 PM. MoneyTV is also broadcast on NBC-TV in the Virgin Islands and Puerto Rico. About Universal Detection Technology
Universal Detection Technology (UDT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://udtt.invrel.net or http://www.udetection.com.
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason.